Medicare Insurance Type and Broad Genomic Profiling in Metastatic Cancer - Top-Institutions - MDSpire

Medicare Insurance Type and Broad Genomic Profiling in Metastatic Cancer

  • By

  • Ryan D. Chow

  • John Rothen

  • Jessica B. Long

  • Pamela R. Soulos

  • Xiao Wang

  • Ronac Mamtani

  • Shuangge Ma

  • Natalia Kunst

  • Michaela A. Dinan

  • Cary P. Gross

  • May 27, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

  • #2

    Yale University
    Yale University

    New Haven, CT

    Key Differentiators

    • Oncology

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology

  • #4

    Georgetown University School of Health
    Georgetown University School of Health

    Washington, DC

    Key Differentiators

    • Oncology

  • #5

    Brigham and Women’s Hospital
    Brigham and Women’s Hospital

    Boston, MA

    Key Differentiators

    • Oncology

Original Source(s)

Medicare Insurance Type and Broad Genomic Profiling in Metastatic Cancer

  • by Ryan D. Chow, John Rothen, Jessica B. Long, Pamela R. Soulos, Xiao Wang, Ronac Mamtani, Shuangge Ma, Natalia Kunst, Michaela A. Dinan, Cary P. Gross

  • May 27, 2026

Related Content

Trametinib as second-line therapy for advanced KRAS G12C-mutant non-small cell lung cancer: a single-center clinical analysis of 20 cases

FOXA2 in cancer: from fundamental biology to clinical translation

Myelodysplastic syndromes complicated by atypical Sweet syndrome: a brief research report